[300 Pages Report] The global next generation mass spectrometer market size reached a valuation of US$ 1,901.7 Million in 2022. Rapid technological advancements in the field of spectrometry, such as the development of miniaturized spectrometers, are major factors driving market revenue growth. The overall sales of next generation mass spectrometers are projected to grow at a robust CAGR of 7.2% between 2022 and 2032, totaling around US$ 4,097.1 Million by the end of 2032.
| Data Points | Key Statistics |
|---|---|
| Next Generation Mass Spectrometer Market Size (2022) | US$ 1,901.7 Million |
| Next Generation Mass Spectrometer Market Revenue Forecast (2032) | US$ 4,097.1 Million |
| Next generation mass spectrometer Market Growth Rate (2022 to 2032) | 7.2% CAGR |
| North America Market Share | 33% |
Next generation mass spectrometers are technologically advanced and application centered. The only platform that generates an upgrade path to high-definition systems is the next generation mass spectrometer. With next-generation mass spectrometers, laboratories can use fewer components with less time to prepare, higher specificity and selectivity, full scan analysis, and simpler mass spectrometry optimization resulting in more comprehensive quantification and retrospective interpretation. With the advancement of new tools and software, next-generation mass spectrometers continue to improve in both resolution and speed at an incredible rate.
The hardware in next-generation mass spectrometers is designed to transport fragile molecules into a gaseous ionized state, where the molecules are then analyzed. Matrix-assisted laser desorption/ionization (MALDI), electrospray ionized particles, and surface-enhanced laser desorption/ionization are instances of next-generation mass spectrometers (SELDI).
Furthermore, the next-generation mass spectrometer has evolved from a large and expensive machine. In addition, the next generation mass spectrometer is utilized to predict a patient's rehabilitation after surgery and the characteristics of immune system response.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The major factor for the growth of the next generation mass spectrometer market is a rise in government spending on life sciences and pharmaceutical study and development.
Furthermore, rising food concerns, clamor in agriculture and medical research, enabling innovative diagnosis, new drug development for diseases, and competitive post-sale and technical assistance, all contributed to a rise in the adaptation of next-generation mass spectrometers.
However, the significantly high cost of the device and a lack of skilled personnel to operate next generation mass spectrometers are some of the key restraints in the market.
Because of increased government investment opportunities in biomedical and biotechnology areas, North America is anticipated to dominate the global next generation mass spectrometer market.
In North America, the key markets for next generation mass spectrometers are the United States and Canada. The market in this region will grow more rapidly than the markets in Europe, Asia Pacific, and South America. Several pharmaceutical companies' greater emphasis on drug research and development will aid the growth of the next generation mass spectrometer market in North America over the forecast timeframe. North America is accounting for a market share of 33% of the global Next generation mass spectrometer market.
Principal Consultant
Furthermore, increased research in the pharmaceutical and medical fields is promoting the growth of global next generation mass spectrometers in the region. Similarly, the huge number of conferences, production, and research facilities of industries in the Asia-Pacific excluding Japan market is expected to drive the growth of the next generation mass spectrometer market throughout the forecast period.
Tandem mass spectrometry devices are in high demand in Europe right now. Diagnostic and therapeutic chemistry and immunoassay techniques are employed in traditional hospital diagnostic assays, which entail analyte-specific reagents and antibodies.
The integration of liquid chromatography and tandem mass spectrometry allows for the unambiguous identification of antibiotic and antibacterial representative traces in complex biological matrices. Elevated research in genetics, particularly proteomics, and the use of alongside next generation mass spectrometers for the same are cruising market growth in Europe. Europe is accounting for a market share of 25.9% of the global Next generation mass spectrometer market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market is divided into applications such as pharmaceuticals, biotechnology, medical research, food and beverage testing, and others. Pharmaceutical industries, for example, have a broad scope of the next generation mass spectrometer due to a rise in cases of adulterated food, drug safety, and new drug advancement for diseases.
Furthermore, medical research has bolstered the global next generation mass spectrometer market. The market is divided into three segments based on end-users: hospitals, research centers, and diagnostic laboratories. Globally, next-generation mass spectrometers are most commonly used in experiments and diagnostic laboratory facilities.
Manufacturers are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interest of potential buyers and create a larger customer base. For instance,
Some of the leading next generation mass spectrometer manufacturers include
Waters Corporation, Thermo Fisher Scientific, Inc., AB Sciex Pte. Ltd., Bruker Corporation, Shimadzu Corporation, anaher Corporation, PerkinElmer, Rigaku, Bio-Rad Laboratories, Jeol Ltd, and Agilent Technologies.
These key next generation mass spectrometer providers are adopting various strategies such as new product launches and approvals, partnerships, collaborations, acquisitions, mergers, etc. to increase their sales and gain a competitive edge in the global Next generation mass spectrometer market. For instance,
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 7.2% from 2022 to 2032 |
| Market Value in 2022 | US$ 1,901.7 Million |
| Market Value in 2032 | US$ 4,097.1 Million |
| Base Year for Estimates | 2021 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in US$ Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Report Customization & Pricing | Available upon Request |
The global next generation mass spectrometer market reached US$ 1,901.7 Million in 2022
As per FMI, the next generation mass spectrometer industry is expected to grow at a CAGR of 7.2% throughout the forecast period (2022 to 2032).
The global sales of next generation mass spectrometers are anticipated to total a valuation of US$ 4,097.1 Million by 2032
North America will continue to remain the most lucrative market for next generation mass spectrometers, accounting for a share of 33% in 2022
1. Executive Summary | Next Generation Mass Spectrometer Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2016 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2016 to 2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Application
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2016 to 2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022 to 2032
5.3.1. Pharmaceuticals
5.3.2. Biotechnology
5.3.3. Medical Research
5.3.4. Food and Beverage Testing
5.3.5. Others
5.4. Y-o-Y Growth Trend Analysis By Application, 2016 to 2021
5.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032
6. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By End user, 2016 to 2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End user, 2022 to 2032
6.3.1. Hospitals
6.3.2. Research centers
6.3.3. Diagnostic laboratories
6.4. Y-o-Y Growth Trend Analysis By End user, 2016 to 2021
6.5. Absolute $ Opportunity Analysis By End user, 2022 to 2032
7. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2016 to 2021
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022 to 2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016 to 2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022 to 2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Application
8.2.3. By End user
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Application
8.3.3. By End user
8.4. Key Takeaways
9. Latin America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016 to 2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Application
9.2.3. By End user
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Application
9.3.3. By End user
9.4. Key Takeaways
10. Europe Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016 to 2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Application
10.2.3. By End user
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Application
10.3.3. By End user
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016 to 2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. Malaysia
11.2.1.5. Singapore
11.2.1.6. Australia
11.2.1.7. Rest of Asia Pacific
11.2.2. By Application
11.2.3. By End user
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Application
11.3.3. By End user
11.4. Key Takeaways
12. MEA Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016 to 2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of MEA
12.2.2. By Application
12.2.3. By End user
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Application
12.3.3. By End user
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. U.K.
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Application
13.1.2.2. By End user
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Application
13.2.2.2. By End user
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Application
13.3.2.2. By End user
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Application
13.4.2.2. By End user
13.5. Rest of Latin America
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Application
13.5.2.2. By End user
13.6. Germany
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Application
13.6.2.2. By End user
13.7. U.K.
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Application
13.7.2.2. By End user
13.8. France
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Application
13.8.2.2. By End user
13.9. Spain
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Application
13.9.2.2. By End user
13.10. Italy
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Application
13.10.2.2. By End user
13.11. Rest of Europe
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Application
13.11.2.2. By End user
13.12. China
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Application
13.12.2.2. By End user
13.13. Japan
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Application
13.13.2.2. By End user
13.14. South Korea
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Application
13.14.2.2. By End user
13.15. Malaysia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Application
13.15.2.2. By End user
13.16. Singapore
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Application
13.16.2.2. By End user
13.17. Australia
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By Application
13.17.2.2. By End user
13.18. Rest of Asia Pacific
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2021
13.18.2.1. By Application
13.18.2.2. By End user
13.19. GCC Countries
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2021
13.19.2.1. By Application
13.19.2.2. By End user
13.20. South Africa
13.20.1. Pricing Analysis
13.20.2. Market Share Analysis, 2021
13.20.2.1. By Application
13.20.2.2. By End user
13.21. Israel
13.21.1. Pricing Analysis
13.21.2. Market Share Analysis, 2021
13.21.2.1. By Application
13.21.2.2. By End user
13.22. Rest of MEA
13.22.1. Pricing Analysis
13.22.2. Market Share Analysis, 2021
13.22.2.1. By Application
13.22.2.2. By End user
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Application
14.3.3. By End user
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Waters Corporation
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. Thermo Fisher Scientific, Inc.
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. AB Sciex Pte. Ltd
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. Bruker Corporation
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. Shimadzu Corporation
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. Danaher Corporation
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. PerkinElmer
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. Rigaku
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.9. Bio-Rad Laboratories
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.10. Jeol Ltd
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
15.1.11. Agilent Technologies.
15.1.11.1. Overview
15.1.11.2. Product Portfolio
15.1.11.3. Profitability by Market Segments
15.1.11.4. Sales Footprint
15.1.11.5. Strategy Overview
15.1.11.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Explore Healthcare Insights
View Reports
Next Generation Mass Spectrometer Market
